Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy
- PMID: 8616845
Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy
Abstract
A unique type of rapidly progressive renal fibrosis, designated Chinese herbs nephropathy (CHN), has been described in young Belgian women who had followed a slimming regimen including recently introduced Chinese herbs (Stephania tetrandra and Magnolia officinalis). Aristolochic acid (AA), a known nephrotoxin and carcinogen, was suspected as its causal factor. To substantiate this hypothesis, renal tissue from five patients with CHN and six patients with other renal diseases was analyzed for the presence of AA-derived DNA adducts, a described biomarker of AA exposure associated with its carcinogenic and mutagenic activity. Using the 32P-postlabeling method, a major distinct DNA adduct spot was found in all five cases of CHN and identified by cochromatographic analyses with authentic markers as the deoxyadenosine adduct of AA-I [7-(deoxyadenosin-N6-yl)-aristolactam I], the major component of the plant extract AA. This DNA adduct was absent in the six control cases. The 7-(deoxyadenosin-N6-yl)-aristolactam I adduct levels in CHN ranged from 0.7 to 5.3/10(7) nucleotides. Our data demonstrate that AA is implicated in CHN. They suggest a mechanism for the urothelial atypia and cancers observed in this disease and raise the possibility that a DNA mutation is responsible for the kidney-destructive fibrotic process.
Similar articles
-
32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.Carcinogenesis. 1997 May;18(5):1063-7. doi: 10.1093/carcin/18.5.1063. Carcinogenesis. 1997. PMID: 9163697
-
Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.Exp Toxicol Pathol. 1999 Jul;51(4-5):421-7. doi: 10.1016/S0940-2993(99)80033-5. Exp Toxicol Pathol. 1999. PMID: 10445409
-
Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.Gen Physiol Biophys. 2001 Dec;20(4):375-92. Gen Physiol Biophys. 2001. PMID: 11989648
-
Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.Drug Saf. 2003;26(1):33-48. doi: 10.2165/00002018-200326010-00004. Drug Saf. 2003. PMID: 12495362 Review.
-
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.Mutagenesis. 2002 Jul;17(4):265-77. doi: 10.1093/mutage/17.4.265. Mutagenesis. 2002. PMID: 12110620 Review.
Cited by
-
Detection and Removal of Aristolochic Acid in Natural Plants, Pharmaceuticals, and Environmental and Biological Samples: A Review.Molecules. 2023 Dec 22;29(1):81. doi: 10.3390/molecules29010081. Molecules. 2023. PMID: 38202664 Free PMC article. Review.
-
Skullcapflavone II, a novel NQO1 inhibitor, alleviates aristolochic acid I-induced liver and kidney injury in mice.Acta Pharmacol Sin. 2023 Jul;44(7):1429-1441. doi: 10.1038/s41401-023-01052-3. Epub 2023 Jan 25. Acta Pharmacol Sin. 2023. PMID: 36697978 Free PMC article.
-
Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.World J Urol. 2023 Apr;41(4):899-907. doi: 10.1007/s00345-022-04100-5. Epub 2022 Jul 22. World J Urol. 2023. PMID: 35867141
-
Aristolochic acid-associated cancers: a public health risk in need of global action.Nat Rev Cancer. 2022 Oct;22(10):576-591. doi: 10.1038/s41568-022-00494-x. Epub 2022 Jul 19. Nat Rev Cancer. 2022. PMID: 35854147 Review.
-
Rare Occurrence of Aristolochic Acid Mutational Signatures in Oro-Gastrointestinal Tract Cancers.Cancers (Basel). 2022 Jan 24;14(3):576. doi: 10.3390/cancers14030576. Cancers (Basel). 2022. PMID: 35158844 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical